BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,699,570 | -23.6% | 151,022 | -7.7% | 0.05% | -16.9% |
| Q2 2023 | $7,455,803 | +3.2% | 163,648 | -8.1% | 0.06% | -3.3% |
| Q1 2023 | $7,221,951 | -27.0% | 178,056 | -8.3% | 0.06% | -29.9% |
| Q4 2022 | $9,899,546 | +1.5% | 194,223 | +7.3% | 0.09% | -2.2% |
| Q3 2022 | $9,750,000 | +2.9% | 181,033 | +22.8% | 0.09% | +18.7% |
| Q2 2022 | $9,471,000 | -11.4% | 147,471 | +7.0% | 0.08% | +17.2% |
| Q1 2022 | $10,686,000 | -4.6% | 137,820 | +5.6% | 0.06% | +10.3% |
| Q4 2021 | $11,206,000 | +28.8% | 130,546 | +20.7% | 0.06% | +11.5% |
| Q3 2021 | $8,701,000 | +26.7% | 108,187 | +26.8% | 0.05% | +30.0% |
| Q2 2021 | $6,867,000 | +20.5% | 85,293 | +26.2% | 0.04% | +8.1% |
| Q1 2021 | $5,699,000 | +15.6% | 67,570 | +10.0% | 0.04% | +19.4% |
| Q4 2020 | $4,930,000 | +60.4% | 61,442 | +60.7% | 0.03% | +40.9% |
| Q3 2020 | $3,074,000 | -28.9% | 38,233 | -23.8% | 0.02% | -33.3% |
| Q2 2020 | $4,321,000 | -24.7% | 50,192 | -29.0% | 0.03% | -43.1% |
| Q1 2020 | $5,736,000 | -36.0% | 70,650 | -34.1% | 0.06% | -13.4% |
| Q4 2019 | $8,958,000 | +20.8% | 107,138 | +26.4% | 0.07% | +13.6% |
| Q3 2019 | $7,413,000 | -12.3% | 84,760 | -17.9% | 0.06% | -14.5% |
| Q2 2019 | $8,451,000 | +9.4% | 103,196 | +8.6% | 0.07% | +9.5% |
| Q1 2019 | $7,726,000 | -3.1% | 95,028 | -21.5% | 0.06% | -7.4% |
| Q4 2018 | $7,970,000 | -11.4% | 121,086 | +3.8% | 0.07% | +15.3% |
| Q3 2018 | $8,996,000 | +12.9% | 116,705 | +8.1% | 0.06% | +11.3% |
| Q2 2018 | $7,969,000 | -82.7% | 107,956 | -84.7% | 0.05% | -52.7% |
| Q1 2018 | $46,022,000 | -8.9% | 707,581 | -9.4% | 0.11% | -6.7% |
| Q4 2017 | $50,509,000 | +7.1% | 781,380 | +3.9% | 0.12% | +8.1% |
| Q3 2017 | $47,171,000 | +1.7% | 751,712 | -1.9% | 0.11% | -9.8% |
| Q2 2017 | $46,390,000 | +8.6% | 766,290 | -7.0% | 0.12% | +6.0% |
| Q1 2017 | $42,716,000 | +4.1% | 823,665 | -11.0% | 0.12% | -0.9% |
| Q4 2016 | $41,026,000 | +3.4% | 925,244 | +11.0% | 0.12% | -4.9% |
| Q3 2016 | $39,676,000 | +0.8% | 833,514 | -4.3% | 0.12% | -0.8% |
| Q2 2016 | $39,374,000 | -2.3% | 870,737 | -11.2% | 0.12% | -2.4% |
| Q1 2016 | $40,292,000 | -12.4% | 980,822 | -18.7% | 0.13% | -5.2% |
| Q4 2015 | $46,006,000 | -2.3% | 1,205,903 | -15.9% | 0.13% | -7.6% |
| Q3 2015 | $47,107,000 | -38.2% | 1,433,955 | +31.5% | 0.14% | -22.9% |
| Q2 2015 | $76,262,000 | +2.1% | 1,090,545 | +0.1% | 0.19% | +6.2% |
| Q1 2015 | $74,657,000 | +4.6% | 1,089,834 | +11.9% | 0.18% | -1.1% |
| Q4 2014 | $71,364,000 | +32.5% | 973,706 | +29.8% | 0.18% | +38.8% |
| Q3 2014 | $53,851,000 | +27.2% | 750,283 | +28.1% | 0.13% | +20.6% |
| Q2 2014 | $42,331,000 | +1.1% | 585,514 | +2.9% | 0.11% | -10.1% |
| Q1 2014 | $41,887,000 | +18.4% | 569,248 | +12.0% | 0.12% | +11.2% |
| Q4 2013 | $35,364,000 | +8.1% | 508,453 | +2.2% | 0.11% | -8.5% |
| Q3 2013 | $32,725,000 | +28.9% | 497,566 | +35.7% | 0.12% | +9.3% |
| Q2 2013 | $25,397,000 | – | 366,626 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |